Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-15 BATE KENNETH Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2017-03-01 Reverberi Gian Piero SVP & Chief Commercial Officer Grant or award +30,000 50,000
2017-03-01 Reverberi Gian Piero SVP & Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2017-03-01 Polymeropoulos Mihael Hristos President and CEO Grant or award +200,000 1,041,848
2017-03-01 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +275,000 275,000
2017-03-01 Kelly James Patrick EVP & Chief Financial Officer Grant or award +70,000 139,721
2017-03-01 Kelly James Patrick EVP & Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2017-03-01 Gulino Richard L. SVP, General Counsel & Sec. Grant or award +30,000 39,100
2017-03-01 Gulino Richard L. SVP, General Counsel & Sec. Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion +12,500 53,165
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion +5,000 58,165
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion +5,000 63,165
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion +7,500 70,665
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Sale +16,300 $15.51 $253K 54,365
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit +12,500 0
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit +5,000 5,000
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit +5,000 10,000
2017-01-03 Baroldi Paolo SVP & Chief Medical Officer Exercise or conversion · Restricted Stock Unit +7,500 22,500
2017-01-03 Gulino Richard L. SVP, General Counsel & Sec. Exercise or conversion +12,500 12,500
2017-01-03 Gulino Richard L. SVP, General Counsel & Sec. Exercise or conversion +7,500 20,000

Page 22 of 36 · 717 trades